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release by adipose tissue macrophages depends on adiposity. However, the
mechanism underlying this association is unknown. In the present study,
we explored the possibility that adipocytes modulate the phenotype of
macrophages, thereby contributing to obesity-induced changes in adipose
tissue.
Methods: Adipocyte conditioned media (ACM) were generated by
culturing adipocytes from IFP (OA patients) or subcutaneous adipose tissue
(ScAT, healthy donors) for 24hrs. Protein and lipid fractions were isolated
using TBME and resuspended in medium. Macrophages were obtained by
differentiating puriﬁed CD14+ monocytes of healthy individuals in the
presence of GM-CSF for 7 days. ACM or different fractions were added for
the last 48h, while LPS was added during the last 24hrs of culture. IL-12
and TNFa cytokine secretionwas measured by ELISA. The Tcell stimulatory
capacity of ACM-conditioned macrophages was measured in a 4-day
mixed lymphocyte reaction. T cell proliferation was measured by tritium-
thymidine incorporation.
Results: Treatment of macrophages with ACM resulted in a strong
reduction in IL-12 secretion upon LPS stimulation, whereas TNFa remained
unaffected. In addition, ACM-conditioned macrophages had an increased T
cell stimulatory capacity. These effects were observed with both IFP- and
ScAT-derived ACM. Interestingly, the inhibition of IL-12 release correlated
to the Body Mass Index (BMI) of the IFP adipocyte donor. Separation of
protein and lipid fractions of ACM indicated that the IL-12 inhibition was
mediated by the lipid fraction. Current research investigates the lipid(s)
responsible for the observed effects.
Conclusions: Macrophage function is modulated by soluble factors
secreted by adipocytes. These factors appear to reside in the lipid fraction
of the ACM. Interestingly, the inhibition of IL-12 release correlates with
BMI of the adipocytes donor, indicating that obesity-related changes in
macrophage phenotype could be mediated by adipocytes.
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MAINTENANCE OF THE PRIMARY CILIUM BY IFT88 PLAYS A ROLE IN
THE CHONDROCYTE INFLAMMATORY RESPONSE TO INTERLEUKIN-1.
A.K. Wann, M.M. Knight. Queen Mary, Univ. of London, London, United
Kingdom
Purpose: To understand the role of the chondrocyte primary cilium in
inﬂammatory signalling. The primary cilium is a relatively understudied
organelle protruding outward into the extracellular space, decorated with
receptors. Its core tubulin structure and ‘proteome’ is maintained by
a speciﬁc set of proteins including dynein motors and those of the intra-
ﬂagellar transport (IFT) family. Many forms of arthritis exhibit elevated
levels of the quintessentially pro-inﬂammatory cytokine IL-1, which up-
regulates the associated pro-catabolic signalling pathways. Recent studies
have shown that the primary cilium is involved in chondrocyte mecha-
notransduction, observed changes in cilia length in osteoarthritis and that
hedgehog signalling, which takes place on the cilium is critical in the
pathogenesis of OA. Here we tested the hypothesis that the primary cilium
is involved in mediating the pathological response to inﬂammatory cyto-
kines and that this occurs through cytokine-induced regulation of cilia
structure.
Methods: To test this we exploited a hypomorphic mutation of Tg737,
encoding for IFT88, which abolishes genesis and growth of the primary
cilium. WT and Tg737 chondrocytes were cultured in monolayer and
treated with IL-1 (10ngml-1). Prostaglandin E2 (PGE2) levels in media
were assessed by ELISA and nitric oxide release indicated by the Greiss
assay. The cilium was labelled with anti-acetylated alpha tubulin anti-
bodies and imaged using confocal microscopy. 3D z-stack reconstructions
were used to assess ciliation and lengths measured using ImageJ software.
Results: IL-1 exposure of WT chondrocytes to IL-1b resulted in dramatic
elevations of PGE2 and nitric oxide levels in the culture media. Intriguingly
for the mutated cells, which lacked cilia, IL-1-induced PGE2 release was
signiﬁcantly attenuated and IL-1-induced nitric oxide release abolished. To
assess if IL-1 elicits its effects by direct inﬂuence on cilia structure we
assessed cilia length in primary cultures where we observed a consistent
w50% increase in length with a range of IL-1 treatments including
different concentrations, times and subtypes. Pharmacological inhibition
of PKA, with the small peptide inhibitor PKI and H89, abolished this IL-1induced increase, which we believe may be a result of complex interfer-
ence with cAMP balance. Additional studies using pharmacological
inhibitors also indicate roles in IL-1-induced cilia elongation for PKC and
the MEK-ERK pathways, already known to be downstream of IL-1 effects.
Conclusions: In conclusion these data show fascinating preliminary
evidence that the primary cilium may have a role in cytokine-induced
inﬂammation. Due to the localised and speciﬁc nature of much of the cilia
proteome, amechanistic understanding of the role of IFT and cilia structure
in inﬂammation may lead to novel therapeutic targets for arthritis and in
other pathologies with an inﬂammatory component.468
DEGREE OF SYNOVITIS ON MRI IS CORRELATED WITH HISTOLOGICAL
AND MACROSCOPIC FEATURES OF SYNOVIAL TISSUE INFLAMMATION
IN KNEE OSTEOARTHRITIS.
B.J. de Lange- Brokaar 1, A. Ioan-Facsinay 1, A.W. Visser 1, S.N. Andersen 1,
L. van Toorn 1, G.J. van Osch 2, A.-M. Zuurmond 3, V. Stojanovic-
Susulic 4, M. Reijnierse 1, R.G. Nelissen 1, T.W. Huizinga 1,
M. Kloppenburg 1. 1 LUMC, Leiden, Netherlands; 2 Erasmus MC, Rotterdam,
Netherlands; 3 TNO, Leiden, Netherlands; 4 Janssen, Pharmaceutical
companies Johnson & Johnson, Radnor, PA, USA
Purpose: Synovitis is often present onMRI of OA knees and is an important
determinant of pain. To better understand the nature of synovitis seen on
MRI we comparedmicroscopic and macroscopic features of synovial tissue
inﬂammation with synovitis grade on contrast enhanced (CE) MRI.
Methods: 22 patients (mean age 617 years, 73 %women, mean BMI 305
kg/mm2) with symptomatic radiographic knee OA attending the rheu-
matology outpatient clinic were included.
Arthroscopy of the index knee was performed and macroscopic features
(neovascularization, villi, ﬁbrin and hyperplasia) were scored (0-4).
Furthermore, 15-20 synovial biopsies per knee were obtained. After hae-
matoxylin and eosin staining, synovial tissue samples were microscopi-
cally scored on features: synovial lining layer hyperplasia/enlargement,
activation of resident cells/stroma and degree of inﬂammatory inﬁltrates.
Each feature was scored from 0-3 and a total sum score per patient was
devised. Mean total scores (0-9) by 3 observers were used.
Saggital and axial T1-weighted Contrast enhanced (CE) MRI images (3T)
were used to semi quantitatively score synovitis at 11 different sites
according to Guermazi et al, ranging from 0-22 [1]. Self reported pain was
assessed by visual analogue scale (VAS, 0-100). Pearson correlations
adjusted for age were used for correlation between total histology syno-
vitis score and total MRI score. Spearman rho correlations were used for
correlation between total histology score and macroscopic features. Both
were calculated by SPSS 16.0.
Results: The mean (SD) synovitis score on MRI was 7.8 (3.9), representing
a mild synovitis, and mean (SD) histology score was 2.1 (1.5). Median
(range) score of macroscopic features (0-4) were 2.0 (1.0-4.0) for neo-
vascularization, 1.0 (0.0-3.0) for hyperplasia, 2.0 (0.0-4.0) for villi and 2.0
(0.0-3.0) for ﬁbrin. Synovitis score on MRI correlated signiﬁcantly with
microscopic synovitis score [r ¼ 0.5, P ¼ 0.019] and macroscopic neo-
vascularization score [r ¼ 0.6, P 0.002] and hyperplasia [r ¼ 0.4, P ¼ 0.40].
Furthermore statistically signiﬁcant correlation between microscopic
synovitis score and macroscopic neovascularization [r ¼ 0.5, P ¼ 0.012]
existed. No signiﬁcant correlations with VAS pain were seen.
Conclusion: Synovitis severity on T1 weighted CE MRI images is signiﬁ-
cantly correlated with both macroscopic and microscopic features of
synovitis in patients with knee OA. No associationwith severity of painwas
seen. Therefore CE MRI evaluation is a reliable, non invasive way to
determine synovitis severity in OA patients.
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TOLL-LIKE RECEPTORS 1, 2, 4, 6, MYD88 OR NALP3 HAVE NO EFFECT IN
A MURINE MODEL OF OSTEOARTHRITIS.
S. Nasi 1, H.-K. Ea 2, F. Lioté 2, A. So 1, N. Busso 1. 1DAL, Service de
Rhumatologie, Ctr. Hosp.ier Univ.ire Vaudois et Université de Lausanne,
Lausanne, Switzerland; 2 Pôle appareil locomoteur, Service de
Rhumatologie, Université Paris Diderot, Hôpital Lariboisière, Paris, France
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S239Purpose: Innate immune response components such as Toll-like receptors
(TLRs), NLRP3 inﬂammasome and the intracellular signaling molecule
MyD88 are all expressed by synovial membrane and chondrocytes.
Previous studies have shown that TLR and NLRP3 inﬂammasome act in
concert to increase IL-1b secretion by activated synovial macrophages and
that IL-1b could be an important mediator involved in the pathogenesis of
osteoarthritis (OA). The aim of our study was to evaluate the role of various
TLRs, NLRP3 and the signaling molecule MyD88 in a murine model of OA
induced by knee menisectomy (MNX, surgical removal of the medial
meniscus).
Methods: Knees from 8-10 weeks old C57Bl6 wild type female (n¼7),
knock-out TLR-1 (n¼5), -2 (n¼7), -4 (n¼8) -6 (n¼5), NLRP3 (n¼9) or
MyD88 (n¼7) were menisectomized, using the sham-operated contralat-
eral knee as a control. 8 weeks later mice were sacriﬁced and knee carti-
lage destruction evaluated by histology using the OARSI scoringmethod. In
addition, apoptotic chondrocytes were quantiﬁed in MyD88- and NLRP3-
deﬁcient knees. Finally, synovial inﬂammation was also scored.
Results: Operated knees exhibit OA symptoms at 8 weeks post-surgery
compared to sham-operated knees as evidenced by both femoral and tibial
cartilage degradation (increased OARSI score parameters, increased
chondrocyte apoptosis) and by synovial inﬂammation. In menisectomized
TLR-1, -2, -4, and -6 deﬁcient mice, severity and extent of cartilage lesions
and synovial inﬂammation were similar to that in MNX wild-type mice.
Using the same approach, we found that the phenotype of NLRP3-deﬁcient
mice was similar to that of wild-type mice. Accordingly, we did not ﬁnd
a signiﬁcant effect of MyD88 deletion, as cartilage erosion and synovial
inﬂammation were similar in MNX knock-out and wild-type mice.
Conclusions: Knee MNX recapitulates features of OA, i.e, cartilage
destruction and synovial inﬂammation. Deﬁciency of TLRs, NLRP3
inﬂammasome and their signaling molecule MyD88 did not impact on the
severity of experimental OA. Our results suggest that NLRP3 inﬂamma-
some is either not involved in IL-1b activation or that IL-1b is not a key
mediator in this murine OA model. This latter hypothesis is strengthened
by the lack of efﬁciency of IL-1b antagonists in the treatment of OA.
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CELECOXIB DECREASES THE PRODUCTION OF CYTOKINES BY
OSTEOARTHRITIC CARTILAGE AND SYNOVIUM WITHOUT AFFECTING
CARTILAGE MATRIX DEGRADATION.
M. Beekhuizen 1, A.I. Tsuchida 1, D.B. Saris 1, W.J. Dhert 1, L.B. Creemers 1,
G.J. van Osch 2. 1UMC Utrecht, Utrecht, Netherlands; 2 Erasmus MC,
Rotterdam, Netherlands
Purpose: Recently, we reported a coculture model with osteoarthritic
cartilage and synovial tissue that is more representative for osteoarthritis
(OA) and useful to study mechanisms of action of OA therapies. Celecoxib,
a COX-2 inhibitor, is frequently used for the treatment of osteoarthritis.
However, its effect on cartilage metabolism has been the subject of much
debate. Moreover, it is unclear how celecoxib affects the levels of soluble
mediators in the joint. In the current study we investigate the effect of
celecoxib on cartilage matrix turnover and the secretion of soluble medi-
ators by cartilage and synovium in a coculture of OA cartilage and synovial
tissue.
Methods: OA cartilage and OA synovium explants were cultured alone or
in coculture for 21 days with the addition of celecoxib at 0.1, 1.0 and 10 mM.
To study cartilage matrix turnover glycosaminoglycan (GAG) content,
production and release were determined. ELISAs for IL-1a, IL-1ß, IL-4, IL-6,
IL-8, IL-10, IL-13, OSM, MCP1, NGF, leptin, adiponectin and PGE2 were
performed on conditioned medium of day 4. For statistical analysis,
univariate analysis of variance was performed, with a randomized block
design to correct for inter-donor variability. P values < 0.05 were consid-
ered signiﬁcantly different.
Results: Both osteoarthritic cartilage and synovial tissue produced PGE2
and celecoxib inhibited the production in a dose dependent manner (P <
0.05; Fig. 1a). Celecoxib, irrespective of the concentration used, did not
show an effect on GAG content, release and production in the coculture
(Fig. 1b). Celecoxib at a concentration of 10 mMdecreased the production of
IL-1a, IL-1ß, IL-6, IL-10, OSM and NGF (P < 0.05). No effect was seen on
leptin, adiponectin, IL-8 and MCP1. IL-13 and IL-4 were not detected
(Fig. 1c).Figure 1. Effect of 10 mM celecoxib on PGE2 production, GAG content, production and
release and soluble mediators in coculture of OA cartilage explants and synovial tissue.
A: Celecoxib decreased PGE2 production (1 representative donor; * P < 0.05). B: No
effect on GAG content, production and release (average +/- sd of 3 OA donors; n¼4
donor/condition). C: Production of IL-1a, IL-1b, IL-6, IL-10, OSM and NGF is decreased
by 10 uM celecoxib (average +/- sd of 3 donors; n¼4 donor/condition; * P < 0.05).
Conclusion: This study shows that celecoxib decreased the production of
multiple soluble mediators associated with inﬂammation and pain in OA.
Although the production of multiple pro-inﬂammatory cytokines and
PGE2 was decreased, no effect on cartilage matrix turnover was seen. The
decreased production of mediators associated with pain in OA, such as
NGF, IL-6 and PGE2 is in line with the effect on pain observed in patients
treated with celecoxib.
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PRO-RESOLVING LIPID MEDIATORS ARE PRESENT IN THE JOINTS OF
OSTEOARTHRITIS PATIENTS
M. Giera 1, C.N. Serhan 2, O.A. Mayboroda 1, M. Kloppenburg 1,
A.M. Deelder 1, R.E. Toes 1, A. Ioan-Facsinay 1. 1 Leiden Univ. Med. Ctr.,
Leiden, Netherlands; 2Brigham and Women's Hosp., Harvard Med. Sch.,
Boston, MA, USA
Purpose: Pro-resolving lipid mediators (LM), such as resolvins, protectins
and maresins, are powerful molecules that have a critical role in limiting
inﬂammation and promoting tissue regeneration. Biochemically they are
derived from the enzymatic oxygenation of poly-unsaturated fatty acids by
lipoxygenases (LOX). Some LOX involved in the generation of pro-resolving
LM have been suggested to play a role in the pathophysiology of osteoar-
thritis (OA) in humans. However, it is currently unclear whether pro-
resolving pathways are activated in the osteoarthritic joint, as the presence
of pro-resolving LM or their precursors was not yet investigated. Therefore,
we aimed at investigating the presence and abundance of pro-resolving
LM and their precursors in synovial ﬂuid (SF) of OA patients compared to
Rheumatoid Arthritis (RA) patients.
Methods: SF samples from OA (n ¼ 8) and RA (n ¼ 9) patients visiting the
outpatient clinic of the department of Rheumatology were collected. A
targeted LC-MS(MS) lipidomics platform based on a QTrap mass spec-
trometer for the highly sensitive determination of several lipid mediators
was used.
Results: The presence of LM could be proven in 4 of the OA and 5 of the RA
patient samples. The pro-resolving LM resolvin D5 and maresin 1 were
readily detectable and were accompanied by the presence of pro-inﬂam-
matory mediators such as leukotriene B4 and anti-inﬂammatory LM, such
as lipoxin A4 and B4. Notably, the pro-inﬂammatory prostaglandins E2 and
D2 could be detected in only 1 OA sample, while they were present in all 5
RA samples. Hydroxy derivatives of polyunsaturated fatty acids (HETE,
HEPE and HDHA) which are precursors and biomarkers for LM were
additionally detected in both patient groups.
Conclusions: This study indicates that a previously unrecognized pathway
is likely activated in the knee joint of OA patients, as evidentiated by the
presence of pro-resolving LM and their precursors in SF of these patients.
